Tuberculosis vaccines help prevention of tuberculosis by boosting a person's immune system to fight the bacteria. Bacille Calmette-Guérin (BCG) vaccine is the only licensed vaccine for tuberculosis currently in use globally. However, the research and development of new vaccines are constantly being done to improve protection and durability further. The global TB vaccine market growth is driven by the rising prevalence of tuberculosis disease globally. As per WHO estimates, about 10 million people fell ill with tuberculosis in 2021.

The Global tuberculosis vaccine market is estimated to be valued at US$ 172.42 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period from 2024 to 2030.

Key Takeaways

Key players operating in the tuberculosis vaccine market are Fujitsu Limited, Mindtree Limited, IBM Corporation, Wipro Limited, Unisys Corporation, CenturyLink Inc., Virtustream Inc. and HCL Technologies Limited.

The rising prevalence of tuberculosis worldwide is a key factor boosting the global Global Tuberculosis Vaccine Market Size. As per WHO data, in 2021, there were an estimated 10.0 million new TB cases worldwide, a 4.5% reduction from the number of new TB cases in 2020. Furthermore, tuberculosis is the thirteenth leading cause of death worldwide and the second leading infectious cause of death after COVID-19. Thus, increasing cases worldwide will drive vaccine demand.

Major technological developments are ongoing in the tuberculosis vaccine space. Companies are focused on developing new vaccines with improved features and better efficacy and durability against the disease. For example, vaccines based on mRNA technology, viral vectors are being developed and tested which can induce better immune response.

Market Trends

Personalized Vaccines - Researchers are exploring options to develop personalized tuberculosis vaccines specific for each individual based on their immune responses, genotypes, and risk factors. This could help enhance protective efficacy of vaccines.

Novel vaccine platforms - Novel vaccine platforms such as mRNA vaccines, viral vectored vaccines, protein subunit vaccines are being explored with promising results in preclinical and clinical trials. If approved, they can help address current limitations with BCG vaccine.

Market Opportunities

Emerging markets - Despite declines in incidence, tuberculosis remains a major challenge in developing nations. Thus emerging countries in Africa, Asia, and Latin America present significant market opportunities for novel tuberculosis vaccines

Booster dose - Given evolving immunity against TB over time, booster doses of TB vaccines are being explored as a strategy to maintain long term protection. This presents an opportunity for higher uptake.

In conclusion, the tuberculosis vaccine market is poised to grow substantially given rising disease burden worldwide and ongoing research on novel technologies and vaccine types with greater efficacy. The market is also expected to benefit from initiatives to boost access to vaccines in high burden low-income countries.

Get More Insights On This Topic: https://medicalinfoblogs.weebly.com/blog/the-rise-of-tuberculosis-vaccine-market-will-drive-preventive-healthcare-sector-growth